Free Trial

Wexford Capital LP Boosts Stake in Exelon Co. (NASDAQ:EXC)

Exelon logo with Utilities background

Wexford Capital LP grew its position in Exelon Co. (NASDAQ:EXC - Free Report) by 506.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 65,217 shares of the company's stock after acquiring an additional 54,464 shares during the period. Wexford Capital LP's holdings in Exelon were worth $2,455,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of EXC. Norges Bank acquired a new position in shares of Exelon in the fourth quarter worth about $479,597,000. Price T Rowe Associates Inc. MD raised its position in shares of Exelon by 37.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 27,618,055 shares of the company's stock worth $1,039,545,000 after purchasing an additional 7,483,873 shares during the last quarter. FMR LLC raised its position in shares of Exelon by 46.9% during the 4th quarter. FMR LLC now owns 17,306,652 shares of the company's stock worth $651,422,000 after purchasing an additional 5,524,103 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of Exelon by 109.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 5,884,282 shares of the company's stock worth $238,608,000 after purchasing an additional 3,068,309 shares during the last quarter. Finally, Vanguard Group Inc. raised its position in shares of Exelon by 2.5% during the 4th quarter. Vanguard Group Inc. now owns 127,335,351 shares of the company's stock worth $4,792,903,000 after purchasing an additional 3,064,673 shares during the last quarter. Institutional investors and hedge funds own 80.92% of the company's stock.

Analyst Upgrades and Downgrades

EXC has been the subject of several research analyst reports. Evercore ISI upped their price target on shares of Exelon from $48.00 to $51.00 and gave the stock an "in-line" rating in a research report on Friday, May 2nd. UBS Group upped their price target on shares of Exelon from $45.00 to $47.00 and gave the stock a "neutral" rating in a research report on Friday, March 21st. Wells Fargo & Company upped their price target on shares of Exelon from $46.00 to $50.00 and gave the stock an "equal weight" rating in a research report on Friday, May 2nd. KeyCorp downgraded shares of Exelon from a "sector weight" rating to an "underweight" rating and set a $39.00 price target for the company. in a research report on Wednesday, May 14th. Finally, Morgan Stanley upped their price objective on shares of Exelon from $46.00 to $48.00 and gave the company an "equal weight" rating in a research note on Thursday, March 20th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, Exelon has an average rating of "Hold" and a consensus target price of $47.30.

Read Our Latest Stock Analysis on Exelon

Exelon Price Performance

EXC stock traded down $0.07 during mid-day trading on Wednesday, reaching $44.19. The company's stock had a trading volume of 6,893,450 shares, compared to its average volume of 7,286,402. The stock has a market cap of $44.61 billion, a PE ratio of 18.04, a P/E/G ratio of 2.86 and a beta of 0.43. The company has a current ratio of 0.87, a quick ratio of 0.78 and a debt-to-equity ratio of 1.61. Exelon Co. has a fifty-two week low of $34.01 and a fifty-two week high of $48.11. The company's 50 day moving average is $45.28 and its two-hundred day moving average is $41.65.

Exelon (NASDAQ:EXC - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.86 by $0.06. The business had revenue of $6.71 billion during the quarter, compared to the consensus estimate of $6.30 billion. Exelon had a net margin of 10.68% and a return on equity of 9.52%. The business's revenue was up 11.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.68 EPS. Equities research analysts expect that Exelon Co. will post 2.64 EPS for the current year.

Exelon Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Monday, May 12th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Monday, May 12th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.62%. Exelon's dividend payout ratio is currently 59.48%.

Exelon Profile

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

See Also

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Should You Invest $1,000 in Exelon Right Now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines